CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858)-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Mento Steven J Director | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2026-01-02 | Bradrick Brittany Director | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2025-12-23 | Van Hoose Kyri K. SVP, CFO | Grant or award | +122,549 | 130,423 | ||
| 2025-12-23 | Van Hoose Kyri K. SVP, CFO | Grant or award · Series C Warrant (Right to Buy) | +122,549 | 122,549 | ||
| 2025-12-23 | Van Hoose Kyri K. SVP, CFO | Grant or award · Series D Warrant (Right to Buy) | +122,549 | 122,549 | ||
| 2025-12-23 | Van Hoose Kyri K. SVP, CFO | Returned to the company · Warrant (Right to Buy) | +7,874 | 0 | ||
| 2025-12-23 | Van Hoose Kyri K. SVP, CFO | Grant or award · Warrant (Right to Buy) | +7,874 | 7,874 | ||
| 2025-12-23 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Grant or award | +490,196 | 490,255 | ||
| 2025-12-23 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Grant or award | +122,549 | 122,563 | ||
| 2025-12-23 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Grant or award · Series C Warrant (Right to Buy) | +490,196 | 490,496 | ||
| 2025-12-23 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Grant or award · Series D Warrant (Right to Buy) | +490,196 | 490,496 | ||
| 2025-12-23 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Grant or award · Series C Warrant (Right to Buy) | +122,549 | 122,549 | ||
| 2025-12-23 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Grant or award · Series D Warrant (Right to Buy) | +122,549 | 122,549 | ||
| 2025-12-23 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Returned to the company · Warrant (Right to Buy) | +78,740 | 0 | ||
| 2025-12-23 | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Grant or award · Warrant (Right to Buy) | +78,740 | 78,740 | ||
| 2025-01-23 | HALE DAVID F Director | Grant or award | +78,741 | 80,957 | ||
| 2025-01-21 | FISHER MARY Director | Grant or award | +196,851 | 196,946 | ||
| 2025-01-21 | FISHER MARY Director | Grant or award · Warrant (Right to Buy) | +196,851 | 196,851 | ||
| 2025-01-21 | Van Hoose Kyri K. SVP, CFO | Grant or award | +78,741 | 78,741 | ||
| 2025-01-21 | Van Hoose Kyri K. SVP, CFO | Grant or award · Warrant (Right to Buy) | +78,741 | 78,741 |
Page 2 of 9 · 172 trades